Biofil Chemicals and Pharmaceuticals Limited Share Price
Equities
BIOFILCHEM
INE829A01014
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.1 INR | +1.92% | +4.74% | +31.59% |
Sales 2022 | 224M 2.68M | Sales 2023 | 300M 3.6M | Capitalization | 674M 8.09M |
---|---|---|---|---|---|
Net income 2022 | 6M 71.94K | Net income 2023 | 5M 59.95K | EV / Sales 2022 | 4.22 x |
Net Debt 2022 | 3.2M 38.34K | Net Debt 2023 | 4.88M 58.48K | EV / Sales 2023 | 2.26 x |
P/E ratio 2022 |
135
x | P/E ratio 2023 |
122
x | Employees | 47 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.72% |
1 day | +1.92% | ||
1 week | +4.74% | ||
Current month | +17.79% | ||
1 month | +17.79% | ||
3 months | +7.13% | ||
6 months | +50.64% | ||
Current year | +31.59% |
Managers | Title | Age | Since |
---|---|---|---|
Ketan Shah
CEO | Chief Executive Officer | 62 | 01/85/01 |
Ramesh S. Shah
CEO | Chief Executive Officer | 87 | 04/85/04 |
Director of Finance/CFO | 33 | 14/22/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ramesh S. Shah
CEO | Chief Executive Officer | 87 | 04/85/04 |
Romil Shah
BRD | Director/Board Member | 39 | 30/05/30 |
Ketan Shah
ADM | Chief Administrative Officer | 62 | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 71.1 | +1.92% | 3 922 |
26/24/26 | 69.76 | -1.70% | 7,492 |
25/24/25 | 70.97 | -2.33% | 9,874 |
24/24/24 | 72.66 | +1.21% | 9,612 |
23/24/23 | 71.79 | -3.96% | 116,870 |
Delayed Quote Bombay S.E., April 29, 2024 at 03:30 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+31.59% | 13.61M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- BIOFILCHEM Stock